.Merck beats incomes requirements, rears sales overview on tough requirement for best medicines like Keytruda CNBCMerck & Co. (MRK US) Trumps Earnings Projections as Keytruda Sales Surge BloombergMerck Supply: Pharma Titan Posts Solid End Results, However Outlook Falls Short Investor's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats earnings and purchases assumptions among Keytruda strong point, however delivers combined full-year outlook MarketWatch.